Literature DB >> 10734042

The Akt proto-oncogene links Ras to Pak and cell survival signals.

Y Tang1, H Zhou, A Chen, R N Pittman, J Field.   

Abstract

The Ras oncogene regulates cellular proliferation, differentiation, transformation, and survival through multiple downstream signals. Ras signals through its effector phosphoinositide 3 (PI3) kinase to the Pak protein kinase (p65(pak)), but the steps from Ras to Pak remain to be elucidated. PI3 kinase can stimulate the small G protein, Rac, a direct activator of Pak, as well as the Akt proto-oncogene, a serine-threonine protein kinase. We found that activated Akt stimulated Pak, whereas a dominant negative Akt inhibited Ras activation of Pak in transfection assays. Akt stimulation of Pak was not inhibited by dominant negative mutants of either Rac or Cdc42 suggesting that Akt activated Pak through a GTPase-independent mechanism. We also developed a novel cell-free system to study Ras activation of Pak. In this system Ras activated Pak only in the presence of a crude cell extract but failed to activate Pak when Akt was immunodepleted from the extract. Akt protects cells from apoptosis through phosphorylation of downstream targets such as the Bcl-2 family member, Bad. We found that activated Pak decreased apoptosis and increased phosphorylation of Bad, whereas dominant negative Pak increased apoptosis and decreased phosphorylation of Bad. These studies define a new oncogene-mediated cell survival signal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734042     DOI: 10.1074/jbc.275.13.9106

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Mutant human cells with constitutive activation of NF-kappaB.

Authors:  Swati S Sathe; Nywana Sizemore; Xiaoxia Li; Kalpa Vithalani; Mairead Commane; Shannon M Swiatkowski; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

2.  p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD.

Authors:  Sophie Cotteret; Zahara M Jaffer; Alexander Beeser; Jonathan Chernoff
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

Review 3.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 4.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 5.  Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.

Authors:  Jeyanthy Eswaran; Da-Qiang Li; Anil Shah; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2012-05-17       Impact factor: 12.531

6.  Identification of phosphorylation sites in betaPIX and PAK1.

Authors:  Mark W Mayhew; Erin D Jeffery; Nicholas E Sherman; Kristina Nelson; Joy M Polefrone; Stephen J Pratt; Jeffrey Shabanowitz; J Thomas Parsons; Jay W Fox; Donald F Hunt; Alan F Horwitz
Journal:  J Cell Sci       Date:  2007-11-15       Impact factor: 5.285

7.  Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis.

Authors:  Andrew E Schade; Jennifer J Powers; Marcin W Wlodarski; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

8.  Pak and Rac GTPases promote oncogenic KIT-induced neoplasms.

Authors:  Holly Martin; Raghuveer Singh Mali; Peilin Ma; Anindya Chatterjee; Baskar Ramdas; Emily Sims; Veerendra Munugalavadla; Joydeep Ghosh; Ray R Mattingly; Valeria Visconte; Ramon V Tiu; Cornelis P Vlaar; Suranganie Dharmawardhane; Reuben Kapur
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

9.  Diacylglycerol kinase zeta regulates actin cytoskeleton reorganization through dissociation of Rac1 from RhoGDI.

Authors:  Hanan Abramovici; Parmiss Mojtabaie; Robin J Parks; Xiao-Ping Zhong; Gary A Koretzky; Matthew K Topham; Stephen H Gee
Journal:  Mol Biol Cell       Date:  2009-02-11       Impact factor: 4.138

10.  Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling.

Authors:  Suresh Guruswamy; Chinthalapally V Rao
Journal:  Gene Regul Syst Bio       Date:  2008-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.